Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)
Titel:
Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)
Auteur:
Huober, Jens Fasching, Peter A. Hanusch, Claus Rezai, Mahdi Eidtmann, Holger Kittel, Kornelia Hilfrich, Jörn Schwedler, Kathrin Blohmer, Jens-Uwe Tesch, Hans Gerber, Bernd Höß, Cornelia Kümmel, Sherko Mau, Christine Jackisch, Christian Khandan, Fariba Costa, Serban Dan Krabisch, Petra Loibl, Sibylle Nekljudova, Valentina Untch, Michael Minckwitz, Gunter von